Nowadays, methods that support the natural process of aging and optimize cellular health are of great interest. In this context, NAD IV Therapy is the innovative support that stands out in the field of health and wellness! This method stands out with its potential to increase energy, support the aging process (well-aging) and optimize overall health. So what is NAD IV Therapy and why should you choose this therapy at Only Health?
What is NAD IV Therapy?
NAD (Nicotinamide Adenine Dinucleotide) is an important coenzyme for the energy production of our cells. As we age, NAD levels naturally decline and as a result, cellular functions may decrease and signs of aging may begin to appear. NAD IV Therapy supports cellular health and optimizes body functions by delivering this valuable molecule directly into the bloodstream.
NAD IV Therapy at Only Health
Only Health is a leading health center specializing in NAD IV Therapy and offering this modality in a safe, comfortable environment. Under the supervision of our certified professionals and physicians, this method offers multifaceted benefits such as boosting energy levels, mental clarity and delaying the signs of aging.
Benefits of NAD IV Therapy:
Energy and Vitality: NAD IV Therapy supports cellular energy production, helping you feel more energized and vibrant throughout the day.
Mental Clarity: Supports memory, concentration and overall mental function.
Optimizing the Aging Process: NAD IV Therapy supports the skin and optimizes the aging process by promoting cellular regeneration.
A Natural Support to Immunity: Supports cellular repair and helps reduce inflammation.
Why Only Health?
At our center, we prepare a support plan tailored to each individual. Your NAD IV Therapy process is customized to your individual needs and uses the most advanced technology and methods to deliver the highest standards of care. Your comfort and safety throughout your treatment is our top priority.
References:
1) Braidy, N., Berg, J., Clement, J., Khorshidi, F., Poljak, A., Jayasena, T., Grant, R., & Sachdev, P.
(2019). Role of Nicotinamide Adenine Dinucleotide and Related Precursors as Therapeutic
Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and
Outcomes. Antioxidants & Redox Signaling, 30(2), 251–294.
https://doi.org/10.1089/ars.2017.7269
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6277084/
2) Covarrubias, A. J., Perrone, R., Grozio, A., et al. (2021). NAD+ metabolism and its roles in
cellular processes during ageing. Nature Reviews Molecular Cell Biology, 22, 119–141.
https://doi.org/10.1038/s41580-020-00313-x
https://www.nature.com/articles/s41580-020-00313-x
3) The Effects of Nicotinamide Adenine Dinucleotide (NAD) on Brain Function and Cognition (NAD).
(ClinicalTrials.gov ID: NCT02942888). Sponsor: The University of Texas Health Science Center at
San Antonio. Information provided by The University of Texas Health Science Center at San
Antonio (Responsible Party). Last Update Posted 2021-09-02.
https://clinicaltrials.gov/study/NCT02942888?tab=history
4) Rajman, L., Chwalek, K., & Sinclair, D. A. (2018). Therapeutic potential of NAD-boosting
molecules: the in vivo evidence. Cell Metabolism, 27(3), 529–547.
https://doi.org/10.1016/j.cmet.2018.02.011
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6342515/
5) Rappou, E., Jukarainen, S., Rinnankoski-Tuikka, R., Kaye, S., Heinonen, S., Hakkarainen, A.,
Lundbom, J., Lundbom, N., Saunavaara, V., Rissanen, A., Virtanen, K. A., Pirinen, E., &
Pietiläinen, K. H. (2016). Weight Loss Is Associated With Increased NAD(+)/SIRT1 Expression
But Reduced PARP Activity in White Adipose Tissue. The Journal of Clinical Endocrinology &
Metabolism, 101(3), 1263-1273. https://doi.org/10.1210/jc.2015-3054
https://pubmed.ncbi.nlm.nih.gov/26760174/
6) Verdin, E. (2015). NAD+ in aging, metabolism, and neurodegeneration. Science, 350(6265),
1208-1213. https://doi.org/10.1126/science.aac485
https://www.science.org/doi/10.1126/science.aac4854
7) Johnson, S., & Imai, S. (2018). NAD+ biosynthesis, aging, and disease. Version 1.
F1000Research, 7, 132. https://doi.org/10.12688/f1000research.12120.1
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5795269/
8) Braidy, N., & Liu, Y. (2020). NAD+ therapy in age-related degenerative disorders: A benefit/risk
analysis. Experimental Gerontology, 132, 110831. https://doi.org/10.1016/j.exger.2020.110831
https://pubmed.ncbi.nlm.nih.gov/31917996/
